News
The U.S. military struck three sites in Iran, directly joining Israel’s war aimed at decapitating the country’s nuclear ...
6h
M539 Restorations on MSNReviving a V12 BMW E38 After 5 Years Outside – Will It Start?We take on the challenge of starting a legendary BMW E38 750iL V12 that’s been sitting abandoned outdoors for 5 years. Dust, ...
Why you should never keep tomatoes in the fridge - and the best way to store them instead ...
Ukraine highlighted how drones can be used in a military or terrorist attack — a concern as the World Cup and Olympics ...
Israel's multilayered air-defense system is credited with protecting the country from serious damage or casualties from past ...
Former congressman Billy Long of Missouri has been confirmed to lead the Internal Revenue Service, an agency he once sought ...
California Gov. Gavin Newsom looked straight into the camera and offered a stark moment for his Democratic Party. The ...
The Innovative Ventures in Early-Stage Technologies Program Provides Damon Runyon Alumni Scientists with Their First Seed Check to Help Fill the Growing Funding Gap in Biotech . N ...
BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted orphan drug ...
Finally, the duo of socks receive a minor upgrade with dual branding embroidery. Check out the collab above. The BEAMS x Polo Ralph Lauren collection drops May 2 via the BEAMS webstore.
enabling the company to activate sites in the U.S. for its ongoing Phase 1/2 trial. Price Action: BEAM stock is down 6.75% at $14.24 at the last check on Monday. UNLOCKED: 5 NEW TRADES EVERY WEEK.
Recently, BEAM reported promising Phase 1/2 data for BEAM-302, demonstrating durable gene correction for AATD. Unfortunately, they concurrently announced a $500 million equity offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results